Lv11
30 积分 2025-10-13 加入
Effects of proprotein convertase subtilisin kexin type 9 modulation in human pancreatic beta cells function
13天前
已完结
Diagnosis and Management of Stable Angina
1个月前
已完结
Pancreatic PCSK9 controls the organization of the β-cell secretory pathway via LDLR-cholesterol axis
1个月前
已完结
Metabolic risk factors and effect of alirocumab on cardiovascular events after acute coronary syndrome: a post-hoc analysis of the ODYSSEY OUTCOMES randomised controlled trial
1个月前
已完结
The associations between exercise and lipid biomarkers
1个月前
已完结
PCSK9 Inhibitors: A Potential Priority Choice for Lipid Management in Patients with Diabetic Kidney Disease
1个月前
已完结
RNA interference versus antibody-based PCSK9 inhibition for the prevention of cardiovascular disease: a drug-target Mendelian randomization study
1个月前
已完结
Effect of proprotein convertase subtilisin/kexin type 9 ( PCSK9 ) monoclonal antibodies on new‐onset diabetes mellitus and glucose metabolism: A systematic review and meta‐analysis
1个月前
已完结
GLP ‐ 1RA and Liver Fibrosis Progression in MASLD and Type 2 Diabetes: Target Trial Emulation Using Propensity Score Matching
5个月前
已完结
Letter by Dong et al Regarding Article, “Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation”
5个月前
已完结
皖公网安备34019202002308